beta-blocker

The term 'beta-blocker' is a modern scientific compound from the mid-20th century. It is constructed from 'beta,' denoting the specific type of adrenergic receptor (classified as beta-1 and beta-2) that the drug targets, combined with the agent noun 'blocker,' indicating the drug's function of obstructing or inhibiting those receptors. The logic is directly descriptive: the drug blocks the beta receptors. This prevents stress hormones like adrenaline from binding to them, thereby slowing the heart rate and reducing blood pressure. The name efficiently conveys both the target and the mechanism of action in a single, transparent compound.

Structure: beta (second) + block (hinder) + er (agent suffix) beta: From the Greek letter 'beta' (β), the second letter of the Greek alphabet. In this compound, it refers to "beta receptors," a specific class of cell receptors in the body. block: From Middle English blok, meaning a log or obstruction. Its functional role is the verb "to block," meaning to hinder or prevent passage or action. er: An English agent noun suffix, indicating a person or thing that performs the action of the verb (e.g., blocker = a thing that blocks).